DeciBio Consulting Names New Partner: Pharma and Biotech Specialist, Andrew Aijian
LOS ANGELES–(BUSINESS WIRE)–#biomarkers–In promoting Andrew Aijian to Partner, DeciBio Consulting announces its first addition to the Partnership since its formation.
Pharmaceuticals, Biotechnology and Life Sciences
LOS ANGELES–(BUSINESS WIRE)–#biomarkers–In promoting Andrew Aijian to Partner, DeciBio Consulting announces its first addition to the Partnership since its formation.
STRASBOURG, France–(BUSINESS WIRE)–#Defymed—Medical technology company Defymed, specialized in the design and development of innovative medical devices for the delivery…
Kraig Biocraft Laboratories have named a new member to its expanded Board of Directors, who will be joining the company as an independent director.
Cerevel Therapeutics is expecting to presented data from studying Tavapadon in patients with early-stage Parkinson’s Disease, at the 2019 International…
Dicerna has announced Retirement of Board of Director Veteran Dennis Langer, and to his place has named Patrick Gray.
San Francisco based clinical-stage biotech company Five Prime Therapeutics has named the new interim Chief Executive Officer, William Ringo, who will start immediately, to replace Aron Knickerbocker, who has resigned to look for new opportunities.
Overall survival data from CheckMate -227 Part 1 evaluating Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) in advanced non-small cell lung cancer featured in ESMO Presidential Symposium
WASHINGTON–(BUSINESS WIRE)–#Medicare–Today, Citizens Against Government Waste (CAGW) released the following comments regarding House Speaker Nancy Pelosi’s (D-Calif.) partisan drug pricing…
Apristor, an oral progesterone receptor antagonist, is being studied in combination with an antiestrogen in advanced ER+,PR+,HER2- endometrial cancer Study…
Tetra Therapeutics has surpassed 50% enrollment – 65% of which are Hispanic patients– in its Phase 2 clinical trial (PICASSO…